Executive Director, Global Program Head
Regeneron Pharmaceuticals
Dr. Mary Peterman is currently Executive Director, Global Program Head Oncology at Regeneron Pharmaceuticals in Tarrytown, New York. Mary joined Regeneron in 2018 and is a team leader in the development of new immuno-oncology drugs, including those involving bispecific monoclonal antibodies. Mary has a passion for advancing the development of new drugs to make a difference for patients, particularly in the fight against cancer. She is also a 20+yr cancer survivor.
Working in the pharmaceutical industry for over 35 years, Mary has contributed to the successful development and approvals of many new drugs in oncology, neuroscience, infectious disease and other therapeutic areas. Prior to joining Regeneron, Mary worked in drug development leadership and project management at Merck for 20 years, and in various research positions at Upjohn (Pfizer) and Teva. She also previously worked as a Pharmacist with patients in hospital and outpatient settings.
Mary graduated from The Ohio State University in Columbus, Ohio (Pharm.D. (Magna Cum Laude) and B.S. Pharmacy) and from Western Michigan University in Kalamazoo, Michigan (MBA). Mary has Canadian roots and, when not working, enjoys spending time with family and friends in Ontario, Canada.